SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-067031
Filing Date
2023-06-01
Accepted
2023-06-01 16:10:28
Documents
14
Period of Report
2023-06-01
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2317482d1_8k.htm   iXBRL 8-K 45387
2 EXHIBIT 3.1 tm2317482d1_ex3-1.htm EX-3.1 9907
3 EXHIBIT 3.2 tm2317482d1_ex3-2.htm EX-3.2 73782
  Complete submission text file 0001104659-23-067031.txt   333434

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tcrr-20230601.xsd EX-101.SCH 3021
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcrr-20230601_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcrr-20230601_pre.xml EX-101.PRE 22587
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2317482d1_8k_htm.xml XML 3822
Mailing Address 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET CAMBRIDGE MA 02142 617-949-5200
TCR2 THERAPEUTICS INC. (Filer) CIK: 0001750019 (see all company filings)

IRS No.: 474152751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38811 | Film No.: 23984733
SIC: 2836 Biological Products, (No Diagnostic Substances)